Introduction
Osteonecrosis is diagnosed by combining clinical suspicion with imaging studies that show reduced blood supply and structural damage in bone. The condition develops when bone tissue does not receive enough blood flow, leading to the death of bone cells and, over time, weakening or collapse of the affected area. Because early osteonecrosis may cause only subtle symptoms, diagnosis often depends on recognizing risk factors and confirming changes that are not visible on ordinary examination alone.
Accurate diagnosis matters because the condition can progress silently before significant joint damage appears. When identified early, especially before the bone surface collapses, treatment may be able to slow progression or preserve joint function. Once collapse has occurred, the options and expected outcome are often different, so establishing the diagnosis as early and precisely as possible is clinically important.
Recognizing Possible Signs of the Condition
The first clue is often pain in a specific joint or bone region, commonly the hip, knee, shoulder, or ankle. The pain is frequently deep, aching, and may worsen with weight-bearing or movement. In early disease, the discomfort may come and go or appear only during activity. As the condition advances, pain can become more constant and may occur at rest or at night.
Symptoms reflect the biology of the disorder. Osteonecrosis begins with impaired blood flow to bone, which compromises the survival of bone cells and the normal process of repair. The affected area may not tolerate mechanical stress well, so pain often increases when the bone is loaded. If the subchondral bone weakens, the joint surface can become irregular or collapse, which may produce stiffness, reduced range of motion, limp, or difficulty using the limb normally.
In some people, symptoms are nonspecific at first. A person may report groin pain that seems to come from the hip, pain in the thigh or buttock, or pain that is mistaken for muscle strain, arthritis, or back problems. Because symptoms can be vague, doctors often consider osteonecrosis when pain is persistent, localized, and not fully explained by a routine examination or basic X-ray.
Medical History and Physical Examination
Diagnosis begins with a detailed medical history. Clinicians ask where the pain is located, when it began, whether it is associated with activity, and whether it has been worsening. They also ask about risk factors known to impair blood supply to bone or increase susceptibility to bone injury. These include corticosteroid use, heavy alcohol consumption, previous trauma or fracture, sickle cell disease, blood clotting disorders, autoimmune disease, prior radiation therapy, organ transplantation, and certain metabolic conditions.
Age and pattern of involvement are also relevant. Osteonecrosis is often seen in adults, but it can occur in younger patients with specific risk factors such as sickle cell disease or steroid exposure. The presence of pain in more than one joint may suggest a systemic cause and can change the diagnostic approach.
During the physical examination, the clinician evaluates tenderness, swelling, warmth, range of motion, and the way the patient walks or bears weight. Limited internal rotation of the hip, pain with joint movement, or a limp may be important findings. The exam does not confirm osteonecrosis by itself, but it helps localize the problem and distinguish joint disease from muscle, tendon, nerve, or spine-related pain. In advanced disease, the joint may show mechanical signs such as crepitus or reduced motion related to surface collapse or degenerative change.
Diagnostic Tests Used for Osteonecrosis
Imaging is central to diagnosis. In many cases, plain radiographs are obtained first because they are widely available and can show later-stage structural changes. However, early osteonecrosis often appears normal on X-ray. As the disease progresses, radiographs may reveal areas of sclerosis, lucency, subchondral fracture, flattening of the femoral head, or collapse of the articular surface. These findings suggest that bone integrity has already been compromised.
Magnetic resonance imaging is the most sensitive test for early osteonecrosis and is often used to confirm suspicion when X-rays are normal or inconclusive. MRI can detect changes in the marrow and bone interface before structural collapse occurs. Typical findings include a geographic lesion, a reactive border, or the classic low-signal rim on certain sequences. MRI is especially useful because it can define the size and location of the lesion, which helps assess risk of progression and guide treatment planning.
Computed tomography may be used when more detail about bone architecture is needed. CT is less sensitive than MRI for early marrow changes, but it can show subtle collapse, fragmentation, or the shape of the subchondral bone with high clarity. It is sometimes helpful when MRI findings need further clarification or when surgical planning requires precise bony detail.
Bone scintigraphy, also called a bone scan, can show areas of altered bone turnover. In osteonecrosis, blood flow and bone metabolism are abnormal, so tracer uptake may be reduced or show a characteristic pattern depending on stage. This test is less specific than MRI, but it may be useful when multiple sites are suspected or when MRI is not available. In some settings, specialized nuclear medicine techniques may help evaluate blood flow and bone activity.
Laboratory tests do not diagnose osteonecrosis directly, but they can help identify associated conditions or exclude other causes of pain. Blood tests may include markers of inflammation, complete blood count, coagulation studies, autoimmune testing, lipid studies, or evaluation for sickle cell disease and other disorders depending on the clinical context. If infection, inflammatory arthritis, or another systemic illness is in the differential diagnosis, laboratory findings may provide important supporting or exclusionary information.
Functional assessment is also part of the workup. Clinicians may observe gait, weight-bearing tolerance, and movement limitations to understand how much the condition affects function. Although not a separate confirmatory test, functional evaluation helps judge severity and may influence urgency of imaging or referral.
Tissue examination is rarely required for routine diagnosis. In unusual or uncertain cases, biopsy or histologic examination may be performed, usually when another disease such as tumor, infection, or inflammatory bone disorder must be excluded. Microscopic examination can show dead bone cells, marrow necrosis, and structural changes consistent with loss of blood supply. Because osteonecrosis is usually identified by clinical and imaging findings, tissue examination is reserved for select situations rather than standard practice.
Interpreting Diagnostic Results
Doctors interpret the results by combining symptoms, risk factors, and imaging findings rather than relying on a single test. A patient with a typical history, localized pain, and an MRI showing a characteristic lesion in the femoral head may be diagnosed with osteonecrosis even if the X-ray is still normal. This is because the disease often begins at the cellular and marrow level before visible collapse occurs.
Interpretation also depends on stage. Early lesions may show preserved joint shape with MRI abnormalities but no radiographic collapse. Later disease is identified when imaging shows subchondral fracture, flattening, or joint-space changes secondary to collapse and arthritis. Staging systems are often used to describe extent and progression because the stage influences prognosis and treatment choices.
When results are unclear, follow-up imaging may be recommended. A stable lesion without collapse may be monitored over time, while progression on serial scans strengthens the diagnosis and changes management. Doctors also consider whether findings fit the patient’s symptoms, because incidental bone abnormalities do not always explain pain.
Conditions That May Need to Be Distinguished
Several disorders can resemble osteonecrosis. In the hip, the most common alternatives include osteoarthritis, transient osteoporosis of the hip, stress fracture, septic arthritis, inflammatory arthritis, and referred pain from the spine. In the knee or ankle, clinicians may also consider meniscal injury, ligament injury, avascular bone lesions from other causes, infection, or degenerative joint disease.
Doctors differentiate these conditions by looking at the pattern of pain, risk factors, physical findings, and imaging characteristics. Osteoarthritis typically shows joint-space narrowing and osteophytes on X-ray, whereas early osteonecrosis may have normal radiographs with MRI evidence of a necrotic segment. Stress fractures can create pain with activity and may appear as linear cortical or trabecular injury rather than a classic necrotic lesion. Infection and inflammatory arthritis are more likely to be associated with systemic symptoms, laboratory abnormalities, joint effusion, or diffuse inflammatory changes.
In children and adolescents, other diagnoses may include Legg-Calve-Perthes disease, slipped capital femoral epiphysis, or bone tumors depending on age and presentation. Careful imaging interpretation is essential because the biological mechanism in osteonecrosis is distinct: the primary problem is ischemic death of bone tissue, not just mechanical wear or inflammation.
Factors That Influence Diagnosis
Several factors affect how osteonecrosis is identified. Disease stage is one of the most important. Early disease is harder to detect on X-ray and often requires MRI, whereas later disease may be visible on simpler imaging. The affected bone also matters. The femoral head is the most common site and is often evaluated with dedicated hip imaging, but osteonecrosis can involve the knee, shoulder, ankle, wrist, jaw, or other bones, each of which may require a different imaging approach.
Patient age influences suspicion. In younger adults, especially those with steroid exposure, alcohol use, or blood disorders, clinicians may think of osteonecrosis earlier. In older adults, symptoms may be attributed to osteoarthritis unless risk factors or imaging suggest otherwise. Underlying disease burden also affects the workup. People with systemic lupus erythematosus, sickle cell disease, transplant history, coagulopathy, or chronic corticosteroid exposure may undergo more prompt and extensive evaluation because their pretest probability is higher.
Timing is another factor. If pain is recent and imaging is early, findings may be subtle. If symptoms have been present for a long time, collapse or secondary arthritis may already be visible, making diagnosis easier but also indicating more advanced disease. Access to MRI, prior surgeries, and the possibility of multifocal disease can further shape the diagnostic pathway.
Conclusion
Osteonecrosis is diagnosed by recognizing a characteristic clinical pattern and confirming it with imaging, most often MRI. Medical history helps identify risk factors that reduce bone blood supply, while the physical examination localizes symptoms and assesses functional impact. X-rays may show later-stage changes, but MRI is usually the key test for early detection. CT, bone scans, laboratory studies, and, in rare cases, tissue examination can add information when the diagnosis is uncertain or another disorder must be excluded.
Because the condition can begin silently and progress to joint collapse, clinicians focus on combining symptom patterns, risk factors, and objective test results. This integrated approach allows osteonecrosis to be identified accurately, staged appropriately, and distinguished from other causes of joint or bone pain.